Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study

Tiina Rauhavirta, Mikko Oittinen, Rami Kivistö, Pekka Männistö, J Arturo Garcia-Horsman, Wang Zhuo, Z Wang, Martin Griffin, Markku Mäki, Katri Kaukinen, Katri Lindfors

Research output: Contribution to journalArticleScientificpeer-review

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)134-142
JournalJOURNAL OF CLINICAL IMMUNOLOGY
Volume33
Issue number1
DOIs
Publication statusPublished - 2013
Publication typeA1 Journal article-refereed

Keywords

  • celiac disease
  • gliadin
  • inhibitor
  • small intestine
  • transglutaminase 2

Publication forum classification

  • Publication forum level 1

Cite this